2026 Eppendorf & ‘Science’ Prize honors breakthrough in 3D mapping of brain lipids

Congratulations to Gioele La Manno (pictured), Ph.D., at École polytechnique fédérale de Lausanne (EPFL), Switzerland, on winning the 2026 Eppendorf & Science Prize for Neurobiology for his pioneering work of whole-brain 3D lipid mapping, providing an atlas of a hidden layer of neural diversity.

“Gioele La Manno’s winning essay describes a new way of thinking about lipids,” said Mattia Maroso, Senior Editor at Science and Chair of the Prize Jury. “Lipids are well-known cellular components that have been considered almost exclusively as structural molecules. Dr. La Manno’s work suggests that lipid heterogeneity defines a hierarchical map of ‘lipizones’ that help define brain regions, cell identities, and physiological states. Deciphering the lipizone map will bring to light new principles of brain organization.”

Lipids form the membranes of brain cells and the myelin that surrounds nerve fibers, but their diversity has been much more difficult to map than the diversity of genes. La Manno and his colleagues developed computational methods to combine millions of imaging mass spectra into the first three-dimensional lipid atlas of the adult mouse brain.

“The findings reveal a layer of brain diversity that has been largely overlooked,” said La Manno. “By making it possible to study where lipids are located and how their distributions change, our work provides a foundation for testing how lipid composition contributes to cell identity, brain function, and disease.”

Two finalists were recognized for pioneering contributions in neurobiology. Zuri Sullivan, Ph.D., Member of the Whitehead Institute for Biomedical Research and the Whitehead Career Development Professor of Biology at MIT in Cambridge USA, has been honored for her work on how the brain distinguishes between different immune challenges to generate distinct states of sickness. Alexander Shakeel Bates, Ph.D., Research Fellow at Harvard Medical School in Boston, USA, has been recognized for building and analyzing central nervous system connectomes in the fruit fly.

Eppendorf and the journal Science have been awarding this prestigious prize since 2002. Since its inception, the Prize has recognized nearly 80 winners and finalists – brilliant young scientists at an early stage of their careers.

This year’s prize was presented for the 25th time on November 15, 2026, in Washington, D.C., USA, during the week of the Society for Neuroscience meeting.

The Eppendorf & Science Prize for Neurobiology addresses early -career scientists. Every year, it honors young scientists who are 35 years of age or younger for outstanding contributions to neurobiological research based on actively performed or directed laboratory work of molecular, cellular, systems, or organismic biology.

The winner receives US$ 25,000, full support to attend the prize ceremony held in conjunction with the Annual Meeting of the Society for Neuroscience, and publication of an essay about their research in Science. The finalists’ essays are published in Science online, and they receive full support to attend the prize ceremony.

The next deadline for applications is June 15, 2027. For more information about all awardees and the Eppendorf & Science Prize for Neurobiology, visit this site.

Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world.

The product portfolio of the business units Liquid Handling, Consumables, Automated Liquid Handling, Separation & Instrumentation and Bioprocess includes, for example pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2025, the Eppendorf Group recorded consolidated revenue of EUR 924 million and invested 60.9 million in R&D.

Eppendorf products are used in academic or industrial research laboratories, such as pharmaceutical, biotech, chemical, and food industries, as well as clinical, environmental, forensic, and industrial laboratories for process analysis, production, and qua lity assurance.

Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 30 countries. The Group employs more than 4,000 people worldwide. They all act in accordance with the purpose of the company’s founders: to improve human living conditions.

www.eppendorf.com